Phase I Study of HeFi-1 to Treat Cancers With CD30 Protein
Clinical trial NCT00048880 · COMPLETED
Trial details
- NCT number
- NCT00048880
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2002-11-05
- Primary completion
- 2008-07-02
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.